Skip to content
★ Sign in to follow
AG

Andreas Gerward

Stayble Therapeutics AB
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 19 Feb 2021 for Stayble Therapeutics AB, €8,957.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Andreas Gerward: trading record in brief

Andreas Gerward appears in our data through filings on Stayble Therapeutics AB shares, published by Finansinspektionen. The record holds 2 filings, for trades running from 4 February 2021 to 16 February 2021.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 19 February 2021 came the latest disclosure, a transaction for €8,957 in Stayble Therapeutics AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Andreas Gerward

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    Verkställande direktör (VD)ExecutivesStayble Therapeutics AB
    90,000 SEK0FI-SE
    15,000 shares@ SEK 6.00BTA (betald tecknad aktie)ISIN SE0015504139FI:csv-671535514da4ae197ad9
  • ●
    Verkställande direktör (VD)ExecutivesStayble Therapeutics AB
    0FI-SE
    315,000 shares0Teckningsrätt/UniträttISIN SE0015504121FI:A001P864-1

2 of 2 declarations